NME2 antibody Usage And Synthesis

Applications

NME2 antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity.

Immunogen

Anti-human NME2 mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human NME2 amino acids 1-152 purified from E. coli.

Background

NME2 takes an important part in the synthesis of nucleoside triphosphates other than ATP. NME2 negatively controls Rho activity by interacting with AKAP13/LBC. NME2 acts as a transcriptional activator of the MYC gene. NME2 binds DNA non-specifically. NME2 is a heterodimeric enzyme functioning as a nucleoside diphosphate kinase. NME1 and NME2 contain 152 amino acids, A and B polypeptide chains of the NM23 enzyme, respectively. NME2 is identical to the beta subunit of human erythrocyte NDP kinase. NDP kinases participate in the synthesis of nucleoside triphosphates, and NM23 is involved in the regulation of signal transduction by complexing with G proteins, causing activation/inactivation of developmental pathways.

NME2 antibody()Related Product Information

• DNMT3A antibody
• KCNH2 Antibody
• Mouse Monoclonal NAPSA Antibody
• PELP1 Antibody
• RAP1GAP antibody
• RAF1 antibody
• NT5E antibody
• GATA6 antibody
• GNAS Antibody (N-Term)
• MSX1 antibody